retractions, culture, cell & molecular biology
Best Places to Work Industry, 2011
Hannah Waters | May 1, 2011
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
New Blood for Gene Therapy
Megan Scudellari | May 1, 2011
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Opinion: The decline of physiology
R.J. Naftalin | Apr 19, 2011
Medical schools in the UK are teaching physiology courses primarily focused on clinical applications with much curtailed practical laboratory training to the detriment of medical education
The Movement of Goods Around the Cell
Patricia Bassereau and Bruno Goud | Apr 1, 2011
A biologist and a physicist collaborate on a decade-long exploration of the physical parameters of membrane traffic in eukaryotic cells.
Family Affair
Megan Scudellari | Apr 1, 2011
In discovering their shared ancestry, a distantly related animal geneticist and plant pathologist find a common thread in their work on immune receptors.
Ancient Anatomy, circa 1687
Ancient Anatomy, circa 1687
Cristina Luiggi | Apr 1, 2011
Seventeenth-century Tibet witnessed a blossoming of medical knowledge, including a set of 79 paintings, known as tangkas, that interweaved practical medical knowledge with Buddhist traditions and local lore.
The “Me Decade” of Cancer
Sarah Greene | Apr 1, 2011
Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.
Optical Tweezers
Patricia Bassereau and Bruno Goud | Apr 1, 2011
Institut Curie researchers Bruno Goud, a biologist, and Patricia Bassereau, a physicist, talk about their fruitful, decade-long collaboration exploring the physics of membrane trafficking in a Skype interview conducted by Associate Editor Richard P. Grant.
Where Cancer and Inflammation Intersect
Where Cancer and Inflammation Intersect
Giorgio Trinchieri | Apr 1, 2011
Recent clinical trials have reignited the interest in simple anti-inflammatory drugs like aspirin for controlling the inflammation associated with cancer. 
An Aspirin for your Cancer?
Giorgio Trinchieri | Apr 1, 2011
Can tumors—which can originate from, and often resemble, chronically inflamed tissue—be curtailed using familiar anti-inflammatory agents, without their side effects?